GreenWood Investors Year End 2023 Letter [Seeking Alpha]
MEI Pharma, Inc. (MEIP)
Last mei pharma, inc. earnings: 2/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.meipharma.com
Company Research
Source: Seeking Alpha
In terms of 2023 returns, our separate accounts, which remain open to any investor, returned 28.0%. Our top 6 positions, accounting for 74% of our accounts & funds' net exposure, grew FCF per share by 39.7% in 2023 using consensus estimates. While our portfolio's mark-to-emotion returns have outpaced broader indexes, we have not borrowed from the future like the indices have, and we believe this bodes well for our forward-looking performance. Dear GreenWood Investor: Fundamental Momentum “Opportunities multiply as they are seized.” —Sun Tzu We are pleased to report a year of good progress for our investors, as our collaborative and constructive engagements added considerable value to our performance. Even still, we are not satisfied. We remain hungry and curious. We're looking for more businesses to bring our active approach to. In terms of 2023 returns, our separate accounts, which remain open to any investor, returned 28.0%. For fund returns, please see our Results page
Show less
Read more
Impact Snapshot
Event Time:
MEIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MEIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MEIP alerts
High impacting MEI Pharma, Inc. news events
Weekly update
A roundup of the hottest topics
MEIP
News
- MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
- MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
- MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
- MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
- MEI Pharma, Inc. (NASDAQ: MEIP) had its "hold" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $7.00 price target on the stock.MarketBeat
MEIP
Earnings
- 2/13/24 - Miss
MEIP
Sec Filings
- 2/29/24 - Form EFFECT
- 2/28/24 - Form 424B5
- 2/21/24 - Form 8-K
- MEIP's page on the SEC website